✦ LIBER ✦

Standard and intermediate risk acute lymphoblastic leukemia in Poland: A report of the Polish Children's Leukemia/Lymphoma Study Group

✍ Scribed by URSZULA RADWANSKA; DANUTA MICHALEWSKA; PAWEL KOLECKI; JERZY ARMATA; WALENTYNA BALWIERZ; JANINA BOGUSLAWSKA-JAWORSKA; ALICJA CHYBICKA; ROMANA CYKLIS; JERZY KOWALCZYK; MARIA OCHOCKA; KATARZYNA PAWELEC; ROMA ROKICKA-MILEWSKA; DANUTA SONTA-JAKIMCZYK; GRAZYNA SLADKOWSKA; ELZBIETA ZELENAY

Book ID: 118712240
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 470 KB
Volume: 37
Category: Article
ISSN: 1328-8067
DOI: 10.1111/j.1442-200x.1995.tb03681.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in CNS protective treatment

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group

✍ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 3 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To

Prognosis and treatment after relapse of

Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985: A report from the childrens cancer study group

✍ W. Archie Bleyer; Harland Sather; G. Denman Hammond 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 3 views

Long-term results of the children's canc

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report

✍ Gaynon, P S; Angiolillo, A L; Carroll, W L; Nachman, J B; Trigg, M E; Sather, H 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Flow cytometric analysis of de novo acut

Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group

✍ Shotaro Iwamoto; Takao Deguchi; Hideaki Ohta; Nobutaka Kiyokawa; Masahito Tsurus 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 235 KB

Randomized comparison of moderate-dose m

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study

✍ Lange, Beverly J.; Blatt, Julie; Sather, Harland N.; Meadows, Anna T. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT

Chemotherapy of residual disease in adul

Chemotherapy of residual disease in adult acute lymphoblastic leukemia (ALL). A randomized study of the eortc leukemia lymphoma study group

✍ P Stryckmans; J.P. Marie; L Debusscher; J Bury; M Peetermans; JM Andrien; G Solb 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 95 KB